{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:14:01Z","timestamp":1792624441654,"version":"4.5.0"},"reference-count":73,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2024,5,3]]},"DOI":"10.1080\/13543776.2024.2364798","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T08:39:05Z","timestamp":1717749545000},"page":"315-332","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["An updated patent review of TRPA1 antagonists (2020 \u2013 present)"],"prefix":"10.1080","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9243-1307","authenticated-orcid":false,"given":"Rosa Maria","family":"Vitale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6131-0470","authenticated-orcid":false,"given":"Luciano","family":"de Petrocellis","sequence":"additional","affiliation":[{"name":"Institute of Biomolecular Chemistry (ICB), National Research Council of Italy (CNR), Pozzuoli (NA), Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6439-7575","authenticated-orcid":false,"given":"Pietro","family":"Amodeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.02.023"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0609598103"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2020.10.014"},{"issue":"4","key":"e_1_3_4_5_1","article-title":"A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment","volume":"218","author":"Balestrini A","year":"2021","unstructured":"Balestrini A, Joseph V, Dourado M, et al. A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment. J Exp Med [Internet]. 2021;218(4). Available from: https:\/\/rupress.org\/jem\/article\/218\/4\/e20201637\/211821\/A-TRPA1-inhibitor-suppresses-neurogenic","journal-title":"J Exp Med [Internet]"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1039\/9781839160752-00201"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.11.023"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c02023"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14367"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2480-9"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2016.03.007"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph11040117"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2020.1815191"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13049"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2020.1797679"},{"key":"e_1_3_4_16_1","unstructured":"Academy of Military Medical Sciences AMMS of PLA. Application of TRPA1 ion channel as drug target in amide herbicide poisoning. CN114903995. 2023."},{"key":"e_1_3_4_17_1","unstructured":"Academy of Military Medical Sciences AMMS of PLA. Application of TRPA1 ion channel as drug target in amide herbicide poisoning. CN117180431. 2023."},{"key":"e_1_3_4_18_1","unstructured":"Academy of Military Medical Sciences AMMS of PLA. Application of TRPA1 ion channel as drug target in paraquat poisoning. CN117205319. 2023."},{"key":"e_1_3_4_19_1","unstructured":"ALGOMEDIX inc. Trpa1 antagonists for treatment of dry eye ocular pain and inflammation. US20200179357. 2020."},{"key":"e_1_3_4_20_1","unstructured":"Altria Client Services. Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products. US20210008140. 2021."},{"key":"e_1_3_4_21_1","unstructured":"Bayer Pharma Aktiengesellschaft. Trpa1 antagonists for the treatment of diseases associated with pain and inflammation. WO2021233752. 2021."},{"key":"e_1_3_4_22_1","unstructured":"Boehringer Ingelheim International Gmbh. Thienopyrimidones as trpa1 inhibitors. WO2021074196. 2021."},{"key":"e_1_3_4_23_1","unstructured":"Boehringer Ingelheim International Gmbh. Thienopyrimidones as trpa1 inhibitors. WO2021074197. 2021."},{"key":"e_1_3_4_24_1","unstructured":"Boehringer Ingelheim International Gmbh. Novel tetrazoles. WO2021074198. 2021."},{"key":"e_1_3_4_25_1","unstructured":"Boehringer Ingelheim International Gmbh. Tetrazole derivatives as trpa1 inhibitors. WO2022002780. 2022."},{"key":"e_1_3_4_26_1","unstructured":"Boehringer Ingelheim International Gmbh. Tetrazole derivatives as trpa1 inhibitors. WO2022002782. 2022."},{"key":"e_1_3_4_27_1","unstructured":"Boehringer Ingelheim International Gmbh. Tetrazole derivatives as trpa1 inhibitors. WO2022079091. 2022."},{"key":"e_1_3_4_28_1","unstructured":"Boehringer Ingelheim International Gmbh. Tetrazole derivatives as trpa1 inhibitors. WO2022079092. 2022."},{"key":"e_1_3_4_29_1","unstructured":"Boehringer Ingelheim International Gmbh. 3h 4h 5h 6h 7h-pyrimido[4 5-b]1 4]oxazine-4 6-dione derivatives as trpa1 inhibitors. WO2022219012. 2022."},{"key":"e_1_3_4_30_1","unstructured":"Boehringer Ingelheim International Gmbh. Uracil derivatives as trpa1 inhibitors. WO2022219013. 2022."},{"key":"e_1_3_4_31_1","unstructured":"Boehringer Ingelheim International Gmbh. 3H 4H-THIENO[2 3-d]PYRIMIDIN-4-ONE DERIVATIVES as TRPA1 INHIBITORS. WO2022219014. 2022."},{"key":"e_1_3_4_32_1","unstructured":"Boehringer Ingelheim International Gmbh. IMIDAZO[4 5-d]PYRIDAZINONYL DERIVATIVES as TRPA1 INHIBITORS. WO2022219015. 2022."},{"key":"e_1_3_4_33_1","unstructured":"Central Hospital Of Minhang District Shanghai. Application of bile acid binding receptor TGR5 in treatment of diarrhea after cholecystectomy. CN115212215. 2022."},{"key":"e_1_3_4_34_1","unstructured":"Chengdu Shibeikang Biological Medicine Technology Co ltd. Pyrazolopyrimidine compound isomer or salt and preparation method and application thereof. CN114656472. 2023."},{"key":"e_1_3_4_35_1","unstructured":"Chengdu Shibeikang Biological Medicine Technology Co ltd. Pyrrolopyrimidine compounds isomers or salts and preparation method and application thereof. CN114656473. 2023."},{"key":"e_1_3_4_36_1","unstructured":"Chengdu Shibeikang Biological Medicine Technology Co ltd. Novel dihydropyrimidine compound isomer or salt and preparation method and application thereof. CN114671875. 2022."},{"key":"e_1_3_4_37_1","unstructured":"Chengdu Shibeikang Biological Medicine Technology Co ltd. Novel theophylline compound isomer or salt and preparation method and application thereof. CN114671876. 2023."},{"key":"e_1_3_4_38_1","unstructured":"Chengdu Shibeikang Biological Medicine Technology Co ltd. Thienopyrimidine compound isomer or salt and preparation method and application thereof. CN114656480. 2024."},{"key":"e_1_3_4_39_1","unstructured":"Chengdu Sport University. Traditional Chinese medicine composition preparation method and application thereof. CN117224608. 2023."},{"key":"e_1_3_4_40_1","unstructured":"Shaw Research DE. L. Pyridazinone compounds as trpa1 inhibitors. WO2023150591. 2023."},{"key":"e_1_3_4_41_1","unstructured":"Shaw Research DE. L. N3-substituted uracil compounds as trpa1 inhibitors. WO2023150592. 2023."},{"key":"e_1_3_4_42_1","unstructured":"Shaw Research DE. L. Pyridone compounds as TRPA1 inhibitors. WO2023215775. 2023."},{"key":"e_1_3_4_43_1","unstructured":"Duke University. Compositions and methods for the treatment of acute and chronic pruritis. WO2020018841. 2020."},{"key":"e_1_3_4_44_1","unstructured":"East China University of Science and Technology. Preparation method of Tibetan medicine juniper extract and application of Tibetan medicine juniper extract in anti-inflammatory and soothing of skin. CN116763688. 2023."},{"key":"e_1_3_4_45_1","unstructured":"Eli Lilly and Co. 2 6-Dioxo -2 3-Dihydro-1H-purine compounds useful for treating disorders related to the activity of the TRPA1 channel. EP3663295. 2020."},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-02863-6"},{"key":"e_1_3_4_47_1","unstructured":"Flonext SRL. Trpa1 channel antagonist compound for use in degenerative retinal diseases. WO2022259133. 2022."},{"key":"e_1_3_4_48_1","unstructured":"Fuzhou Baicaotang Pharmaceutical Technology Co ltd. Dihydroartemisine D glucoside or salt compound thereof and application thereof in cosmetics. CN110981925. 2021."},{"key":"e_1_3_4_49_1","unstructured":"Guangzhou Junyuankang Biotechnology Co Ltd. Application of TRPA1 inhibitor in preparation of medicines for treating inflammation. CN111150847. 2020."},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010232"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-020-03818-3"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12192-020-01131-y"},{"key":"e_1_3_4_53_1","unstructured":"Guangzhou Medical University. Use of sesquiterpenoid compound in inhibiting trpa1 channel activity. WO2023202102. 2023."},{"key":"e_1_3_4_54_1","unstructured":"GYEONGGIDO BUSINESS amp; SCIENCE ACCELERATOR. Composition for treating alleviating or preventing pain containing bupleurum falcatum extract or component thereof. KR1020200052221. 2020."},{"key":"e_1_3_4_55_1","unstructured":"Hangzhou Westan Pharmaceutical Technology Co. L. Heteroaromatic acetamide derivative and preparation and use thereof. WO2020244460. 2020."},{"key":"e_1_3_4_56_1","unstructured":"George Edward Hoag JS. Composition and method for treating the lungs. WO2020086759. 2020."},{"key":"e_1_3_4_57_1","unstructured":"Korea Institute of Ocean Science & Technology. Composition comprising sea cucumber-derived saponin compound for preventing alleviating or treating neuropathy. WO2021187679. 2021."},{"key":"e_1_3_4_58_1","unstructured":"Nagoya City University AMU. Pulmonary arterial pulmonary hypertension treatment agent and use thereof. JP2021165251. 2021."},{"key":"e_1_3_4_59_1","unstructured":"Nantong University. Application of transient receptor potential ankyrin 1 ion channel antagonist. CN114712364. 2022."},{"key":"e_1_3_4_60_1","unstructured":"Nippon Menard Cosmetic Co Ltd. TRP channel activity inhibitor. JP2023180673. 2023."},{"key":"e_1_3_4_61_1","unstructured":"Olix Pharmaceuticals Inc. Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Ra TRPA1 or F2RL1. US20200109405. 2021."},{"key":"e_1_3_4_62_1","unstructured":"Rohto Pharmaceutical Co Ltd. External composition for skin. JP2023059139. 2023."},{"key":"e_1_3_4_63_1","unstructured":"Shanghai Zhaoyu Medicine Technology Co ltd. Oxazole pyrimidone amide compound or medicinal salt thereof preparation method and application. CN112794860. 2021."},{"key":"e_1_3_4_64_1","unstructured":"South Central University for Nationalities. Application of folium artemisiae argyi volatile oil serving as TRPA1 pathway inhibitor in anti-inflammatory and antipruritic medicines. CN115944662. 2023."},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114404"},{"key":"e_1_3_4_66_1","unstructured":"The Johns Hopkins University TTOCUITCONY. Treatment and prevention of trigeminal neuralgia. WO2023133502. 2023."},{"key":"e_1_3_4_67_1","unstructured":"Universit\u00e9 Grenoble Alpes INDLSEDLRM. Astrocytic trpa1 channel inhibition as a novel neuroprotective therapeutic target in the prodromal phases of alzheimer\u2019s disease. WO2022058946. 2022."},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-017-0541-z"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awab281"},{"key":"e_1_3_4_70_1","unstructured":"Xuzhou Central Hospital. Polypeptide TAT-TRPA1-C-peptide and application thereof. CN116693698. 2023."},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-019-00083-1"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0557-z"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3024"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120709"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543776.2024.2364798","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T12:27:25Z","timestamp":1727267245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543776.2024.2364798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,3]]}},"alternative-id":["10.1080\/13543776.2024.2364798"],"URL":"https:\/\/doi.org\/10.1080\/13543776.2024.2364798","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-02-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}